Janssen Scientific Affairs, Llc

This study compares the long-term safety of ustekinumab (Stelara) against other biologic drugs for adults with Crohn's disease or ulcerative colitis. Researchers will analyze military health records to track rates of cancer and serious infections in over 1,000 patients starting t…

This program provides access to a specialized cell therapy called cilta-cel for patients with serious multiple myeloma when standard treatment options aren't available or feasible. The therapy involves modifying a patient's own immune cells to target cancer cells. This is for pat…